Free Trial

CorVel (CRVL) Competitors

$239.85
-0.30 (-0.12%)
(As of 05/31/2024 ET)

CRVL vs. GSHD, SLQT, CRD.A, HIIQ, GOCO, LH, DGX, DVA, CHE, and RCM

Should you be buying CorVel stock or one of its competitors? The main competitors of CorVel include Goosehead Insurance (GSHD), SelectQuote (SLQT), Crawford & Company (CRD.A), Health Insurance Innovations (HIIQ), GoHealth (GOCO), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), and R1 RCM (RCM).

CorVel vs.

Goosehead Insurance (NASDAQ:GSHD) and CorVel (NASDAQ:CRVL) are both mid-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, community ranking, profitability, earnings, risk, analyst recommendations and media sentiment.

51.4% of CorVel shares are owned by institutional investors. 48.4% of Goosehead Insurance shares are owned by company insiders. Comparatively, 48.7% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Goosehead Insurance currently has a consensus price target of $73.80, suggesting a potential upside of 14.42%. Given CorVel's higher probable upside, analysts plainly believe Goosehead Insurance is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Goosehead Insurance
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.60
CorVel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

CorVel has a net margin of 9.59% compared to CorVel's net margin of 5.99%. CorVel's return on equity of 202.00% beat Goosehead Insurance's return on equity.

Company Net Margins Return on Equity Return on Assets
Goosehead Insurance5.99% 202.00% 5.44%
CorVel 9.59%33.49%17.42%

In the previous week, CorVel had 5 more articles in the media than Goosehead Insurance. MarketBeat recorded 11 mentions for CorVel and 6 mentions for Goosehead Insurance. CorVel's average media sentiment score of 0.85 beat Goosehead Insurance's score of 0.28 indicating that Goosehead Insurance is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Goosehead Insurance
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CorVel
3 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

CorVel has higher revenue and earnings than Goosehead Insurance. CorVel is trading at a lower price-to-earnings ratio than Goosehead Insurance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Goosehead Insurance$261.28M9.38$14.14M$0.62104.03
CorVel$795.31M5.16$76.25M$4.4054.51

Goosehead Insurance received 82 more outperform votes than CorVel when rated by MarketBeat users. However, 64.38% of users gave CorVel an outperform vote while only 60.27% of users gave Goosehead Insurance an outperform vote.

CompanyUnderperformOutperform
Goosehead InsuranceOutperform Votes
270
60.27%
Underperform Votes
178
39.73%
CorVelOutperform Votes
188
64.38%
Underperform Votes
104
35.62%

Goosehead Insurance has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500. Comparatively, CorVel has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500.

Summary

CorVel beats Goosehead Insurance on 9 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRVL vs. The Competition

MetricCorVelInsurance agents, brokers, & service IndustryBusiness SectorNASDAQ Exchange
Market Cap$4.11B$17.68B$6.71B$7.99B
Dividend YieldN/A2.75%2.70%4.00%
P/E Ratio54.5126.3520.2618.59
Price / Sales5.1624.43578.1277.18
Price / Cash40.0125.4129.5431.55
Price / Book16.597.944.724.59
Net Income$76.25M$954.11M$119.57M$213.90M
7 Day Performance-13.29%-0.75%-0.33%0.87%
1 Month Performance-0.71%6.27%0.46%1.82%
1 Year Performance17.28%4.58%5.11%5.90%

CorVel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GSHD
Goosehead Insurance
4.1751 of 5 stars
$65.14
+1.2%
$73.80
+13.3%
+15.3%$2.47B$261.28M105.061,415Short Interest ↑
News Coverage
SLQT
SelectQuote
1.6408 of 5 stars
$3.00
-0.3%
$4.00
+33.6%
+97.5%$506.63M$1.00B-9.364,186Short Interest ↑
CRD.A
Crawford & Company
0 of 5 stars
$9.17
-3.6%
N/A-8.1%$451.16M$1.32B19.949,000
HIIQ
Health Insurance Innovations
0 of 5 stars
N/AN/AN/A$440.51M$381.81M11.04222Gap Down
High Trading Volume
GOCO
GoHealth
0.8411 of 5 stars
$10.11
+3.1%
$13.00
+28.6%
-46.2%$229.80M$734.67M-1.422,530
LH
Laboratory Co. of America
4.8757 of 5 stars
$196.19
-1.7%
$243.14
+23.9%
-8.3%$16.54B$12.16B39.4767,000Analyst Forecast
DGX
Quest Diagnostics
4.8864 of 5 stars
$138.91
-1.7%
$146.17
+5.2%
+5.9%$15.43B$9.25B18.7048,000Analyst Forecast
DVA
DaVita
3.172 of 5 stars
$143.67
+3.7%
$144.67
+0.7%
+55.3%$12.60B$12.14B16.3370,000Analyst Upgrade
CHE
Chemed
4.8488 of 5 stars
$543.67
-2.1%
$673.50
+23.9%
+4.0%$8.23B$2.26B29.2615,087
RCM
R1 RCM
4.7417 of 5 stars
$12.75
+2.2%
$16.31
+27.9%
-21.7%$5.37B$2.25B-159.3830,000Positive News

Related Companies and Tools

This page (NASDAQ:CRVL) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners